Bringing Clinical Trials to Life

Dermatology

Together, Cu-Tech and Synteract create the leading dermatology CRO, with global capabilities and unparalleled access to sites and patients. Our focus on novel and required dermatology drugs provides dedicated research services unmatched in the market.
More...

Neuro Degenerative

Neuro degenerative disorders are some of the most confounding and complex to affect people. Our specialized experience in these trials aids you in developing treatments that improve functioning and help the lives of both patients and caregivers…
More...

Oncology

Like our clients, we are committed to the quest to cure cancer. But cancer is not just a single disease. It takes deep trial knowledge to know how to address its many forms. Learn how Synteract has stayed ahead of the trends leading towards new treatments…
More...

Pediatrics

Pediatric trials run the gamut of indications in drug development, but they all have primary things in common – working with children and their families requires specialized expertise and deep knowledge of regulatory requirements….
More...

Rare & Orphan Diseases

Rare and orphan diseases have unique characteristics, not the least of which is finding the right population for your trials. We know the investigators and study sites that can help to address your recruitment goals, among other challenges…
More...

2/18/2019 - 2/21/2019 : SCOPE More...

2/11/2019: Synteract is exhibiting at several upcoming industry trade shows this February and March. More...

2/6/2019: The Promise of Precision Medicine: Advances in Oncology Clinical Trials – Part I - We sat down with our Vice President Oncology Development at, Etienne Drouet, to get his perspective on advanced diagnostics, genomics, and precision medicine in oncology clinical trials.

Synteract Blog 

2/18/2019: Over the past 30 years, we have completed trials across a spectrum of cancer therapies. Consider how our experience can bring your next #oncology trial to life: http://ow.ly/SSnm50lCksx

Synteract on LinkedIn

2/18/2019: Good morning from SCOPE! Make sure to carve out some time to meet with our experts to find out how we can address y… https://t.co/7CqqsEHhIB

Synteract Twitter Feed
x

Submit RFI / RFP

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

Required

x

Contact Synteract

Tell us how to stay in touch with you:

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

Required

x

Download Resource

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

*Required